The occurrence of Type II (non-insulin-dependent) diabetes and obesity and their associated morbidities continue to increase and they are rapidly reaching epidemic proportions. AMPK (AMP-activated protein kinase) was initially thought of as an intracellular ‘fuel gauge’ responding to a decrease in the level of ATP by increasing energy production and decreasing energy utilization. Recent studies have shown that AMPK plays a role in controlling the whole body energy homoeostasis, including the regulation of plasma glucose levels, fatty acid oxidation and glycogen metabolism. In addition to its effects on the periphery, AMPK has been found to play a key role in the control of food intake through its regulation by hormones, including leptin, within the hypothalamus. The control of AMPK activity, therefore, provides an attractive target for therapeutic intervention in metabolic disorders such as obesity and Type II diabetes. Indeed, a number of physiological and pharmacological factors that are beneficial in these disorders have been shown to act, at least in part, through the activation of AMPK.
Skip Nav Destination
Article navigation
April 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
April 01 2005
AMP-activated protein kinase and the metabolic syndrome
L.G.D. Fryer;
L.G.D. Fryer
1
1Cellular Stress Group, MRC Clinical Sciences Centre, Imperial College, Hammersmith Hospital, DuCane Road, London W12 0NN, U.K.
1Correspondence may be addressed to either of the authors (email l.fryer@imperial.ac.uk or dcarling@imperial.ac.uk).
Search for other works by this author on:
D. Carling
D. Carling
1
1Cellular Stress Group, MRC Clinical Sciences Centre, Imperial College, Hammersmith Hospital, DuCane Road, London W12 0NN, U.K.
1Correspondence may be addressed to either of the authors (email l.fryer@imperial.ac.uk or dcarling@imperial.ac.uk).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
October 26 2004
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2005 The Biochemical Society
2005
Biochem Soc Trans (2005) 33 (2): 362–366.
Article history
Received:
October 26 2004
Citation
L.G.D. Fryer, D. Carling; AMP-activated protein kinase and the metabolic syndrome. Biochem Soc Trans 1 April 2005; 33 (2): 362–366. doi: https://doi.org/10.1042/BST0330362
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.